Literature DB >> 1593682

Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence.

S C Kim1, M M Oh.   

Abstract

The levels of catecholamines in penile blood during a papaverine test were measured to investigate whether the secretion of endogenous catecholamines is involved in response to intracorporeal papaverine injection. The level of norepinephrine was higher in patients with psychogenic impotence than in the normal controls and patients with vasculogenic impotence (p less than 0.01), and it was significantly higher in negative responders than in positive responders in the psychogenic impotence group (p less than 0.001). There was no significant difference in the level of epinephrine among the groups. The false negative response to the papaverine test in psychogenically impotent men is believed to be derived from secretion of cavernous norepinephrine, which overwhelms the action of cavernous smooth muscle relaxation by papaverine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593682     DOI: 10.1016/s0022-5347(17)37617-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 2.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

Review 3.  Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis.

Authors:  Ahmed Mohamed Hassanin; Ahmed Zain Abdel-Hamid
Journal:  Int Urol Nephrol       Date:  2019-10-15       Impact factor: 2.370

4.  Correlation between peak systolic velocity and diameter of cavernosal arteries in flaccid versus dynamic state for the evaluation of erectile dysfunction.

Authors:  R Souper; J Hartmann; M Alvarez; I Fuentes; G Astroza; M Marconi
Journal:  Int J Impot Res       Date:  2017-04-06       Impact factor: 2.896

5.  Diagnostic value of radionuclide phallography with intravenous vasodilator stress in the evaluation of arteriogenic impotence.

Authors:  Q H Siraj; A J Hilson
Journal:  Eur J Nucl Med       Date:  1994-07

6.  Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target.

Authors:  Silvia Giatti; Alessandro Di Domizio; Silvia Diviccaro; Eva Falvo; Donatella Caruso; Alessandro Contini; Roberto Cosimo Melcangi
Journal:  J Med Chem       Date:  2021-04-12       Impact factor: 7.446

7.  Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin®) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series.

Authors:  Francois Giuliano; Pierre Denys; Charles Joussain
Journal:  Toxins (Basel)       Date:  2022-04-16       Impact factor: 5.075

Review 8.  Oral and injectable medications for the treatment of erectile dysfunction.

Authors:  C C Carson
Journal:  Curr Urol Rep       Date:  2000-12       Impact factor: 2.862

9.  A syndrome of erectile dysfunction in young men?

Authors:  Amanda B Reed-Maldonado; Tom F Lue
Journal:  Transl Androl Urol       Date:  2016-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.